<p>An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in the trial were all critically unwell with ARDS, caused by severe Covid-19, and the invariant natural killer T (iNKT) cell therapy triggered an immune response in these individuals. The results are published in the journal <em>Nature Communications.</em></p>
Almost 40,000 cancers went undiagnosed during the first year of Covid, according to official statistics which lay bare the 'true and catastrophic impact' of the pandemic. Just 290,000 people in England were told they had cancer in 2020, down by.
Just 290,000 people in England were told they had cancer in 2020, down by a tenth on one year earlier - the biggest drop logged since records began 50 years ago.
Professor Sikora, 74, is the founding dean of the University of Buckingham Medical School and a former clinical director of cancer services for Hammersmith and Charing Cross.